Vaccine factory to be built in Khazaen City, Oman worth RO 20 million
The Khazaen Economic City has signed a contract for RO 20 million with Opal for Biopharmaceuticals and Business Company for the establishment of a factory to manufacture biological human vaccines. During the first phase of the project, 37,000 square meters of area will be set aside for the construction.
The agreement was signed by Eng. Salim Al Thuhli, CEO of Khazaen and Sa’ad Moosa Al Junaibi, Chairman of the Board of Directors of Opal for Biopharmaceuticals and Business Company. Al Thuhli said that the project will be the first vaccine plant in Khazaen Economic City and it targets both the local and international market. Announcing the agreement, Al Thuhli added, Khazaen is taking steps to seek and attract both local and international investment.